Avident Health & Unite for HER Win Pfizer-NCCN Grant for mBC Care

Avident Health LLC, a pioneer in digital oncology navigation and caregiver-inclusive care coordination, and Unite for HER, a national non-profit providing integrative therapies to breast and ovarian cancer patients, have been awarded an independent quality improvement grant funded collaboratively by Pfizer Inc. and the National Comprehensive Cancer Network® (NCCN®). The project will deploy Avident Health's proprietary MyNavigator™ digital platform to enhance care delivery for patients with metastatic breast cancer (mBC), bridging critical communication gaps between clinic visits and driving enrollment in Unite for HER's free supportive services.

The MyNavigator platform will serve as an interactive, home-based companion that delivers tailored NCCN Guideline education, streamlines access to integrative supportive care such as nutrition counseling and mental health services, engages informal family caregivers in a secure communication loop, and enables proactive care team interventions through patient-reported check-ins. Dr. Maen Farha of Avident Health emphasized that the collaboration creates a continuous circle of support, while Sue Weldon, Founder and CEO of Unite for HER, noted that the platform reaches patients and families at the exact moment they need guidance. The initiative will measure quality improvement endpoints including patient knowledge concordance with NCCN Guidelines, supportive service utilization, decisional conflict, and therapy adherence.

This grant-funded effort highlights the growing role of digital health in oncology, combining Avident Health's www.avidenthealth.com technology with Unite for HER's www.uniteforher.org integrative services and NCCN's www.nccn.org gold-standard guidelines. By empowering patients and caregivers, the project aims to improve treatment adherence and quality of life for those living with metastatic breast cancer.